6:2 Cl-PFESA, a proposed safe alternative for PFOS, diminishes the gemcitabine effectiveness in the treatment of pancreatic cancer
Jiawei Hong, Keyi Du, Weichen Zhang, Junran Chen, Hangbiao Jin, Yuanchen Chen, Yifan Jiang, Hanxi Yu, Xiaoyu Weng, Shusen Zheng, Jun Yu, Linping Cao
Topics & Concepts
GemcitabinePancreatic cancerRibonucleotide reductaseDownregulation and upregulationCancer researchOncologyMedicineChemotherapyInternal medicineCancerPharmacologyBiologyGeneticsGeneProtein subunitPancreatic and Hepatic Oncology ResearchCancer Genomics and DiagnosticsEpigenetics and DNA Methylation